Author:
Khanna Vamika,Singh Kavita
Publisher
Springer Science and Business Media LLC
Reference124 articles.
1. Gomes F, Cheng SL (2023) Pathophysiology, therapeutic targets, and future therapeutic alternatives in COPD: focus on the importance of the cholinergic system. Biomolecules 13:476
2. WHO (2023) Chronic obstructive pulmonary disease (COPD). https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed 30 Sep 2023
3. Polosukhin VV, Gutor SS, Du RH, Richmond BW, Massion PP, Wu P, Cates JM, Sandler KL, Rennard SI, Blackwell TS (2021) Small airway determinants of airflow limitation in chronic obstructive pulmonary disease. Thorax 76:1079–1088
4. Macklem PT (2010) Therapeutic implications of the pathophysiology of COPD. Eur Respir J 35:676–680
5. Brashier BB, Rahul K (2012) Risk factors and pathophysiology of chronic obstructive pulmonary disease (COPD). J Assoc Physicians India 60:17–21